Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application

Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application

Abstract Pulmonary fibrosis (PF) is a chronic, progressive, fibrotic interstitial disease of the lung with poor prognosis and without effective treatment currently. Data from previous coronavirus infections, such as the Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome, a...

Full description

Bibliographic Details
Main Authors: Yunyu Zhao, Zhipeng Yan, Ying Liu, Yue Zhang, Jie Shi, Jingtao Li, Fanpu Ji
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Stem Cell Research & Therapy
Subjects:
Pulmonary fibrosis
Mesenchymal stem cells
COVID-19
SARS-CoV-2
Bleomycin
Systematic review
Online Access:https://doi.org/10.1186/s13287-021-02551-y

Internet

https://doi.org/10.1186/s13287-021-02551-y

Similar Items